Journal of Clinical Endocrinology & Metabolism, Vol 75, 1173-1175, Copyright © 1992 by Endocrine Society

ARTICLES

Parathyroid hormone-related protein mRNA in avascular human amnion

AM Germain, H Attaroglu, PC MacDonald and ML Casey
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas.

Previously, we found that preproendothelin-1 mRNA is present in human avascular amnion tissue. In this investigation, we evaluated the possibility that another vasoactive protein, namely, parathyroid hormone-related protein (PTH-rP), also is produced in amnion. Using a specific cDNA probe, we identified PTH-rP mRNA in amnion tissue and found that the level of PTH-rP mRNA in placental amnion was greater than that in reflected amnion tissue obtained from the same pregnancy. PTH-rP mRNA also was demonstrable in chorion laeve and in decidua, but the levels of this mRNA in these tissues were much lower than that in amnion. By radioimmunoassay, we found that human amnion cells in primary monolayer culture secrete immunoreactive PTH-rP into the medium. Importantly, the placental amnion covers the chorionic vessels that traverse over the chorionic plate prior to branching into the cotelydons; specifically, there is no intervening tissue between placental amnion and the adventitial tissue of the chorionic vessel wall. Thus, the potential exists for the production of endothelin-1, a potent vasocontractant, and PTH-rP, a vasorelaxant, in placental amnion for export to the adventitial surface of the chorionic vessels. Moreover, amnion cells respond to a number of agents (e.g., transforming growth factor-beta) that effect changes in the expression of these two peptides. Therefore, the possibility should be considered that amnion-derived vasoactive proteins may modulate fetal chorionic, umbilical, and villous vessel tone and thereby fetal-placental blood flow.

This article has been cited by other articles:

				A. Komatsu, S. Kozuma, H. Hyodo, T. Horikoshi, K. Sakamaki, A. Kikuchi, Y. Kamei, T. Fujii, and Y. Taketani Changes in Umbilical Arterial Blood Flow by an Intraamniotic Distilled Water Infusion Reproductive Sciences, April 1, 2006; 13(3): 166 - 173. [Abstract] [PDF]

				C.S. Thota, L.C. Reed, and C. Yallampalli Effects of Parathyroid Hormone Like Hormone (PTHLH) Antagonist, PTHLH7-34, on Fetoplacental Development and Growth During Midgestation in Rats Biol Reprod, December 1, 2005; 73(6): 1191 - 1198. [Abstract] [Full Text] [PDF]

				M. E. Wlodek, K. T. Westcott, R. O'Dowd, A. Serruto, L. Wassef, K. M. Moritz, and J. M. Moseley Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1620 - R1627. [Abstract] [Full Text] [PDF]

				M. E. Wlodek, K. T. Westcott, P. W. M. Ho, A. Serruto, R. Di Nicolantonio, W. Farrugia, and J. M. Moseley Reduced fetal, placental, and amniotic fluid PTHrP in the growth-restricted spontaneously hypertensive rat Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R31 - R38. [Abstract] [Full Text] [PDF]

				E. P. Spaziani, W. F. O'Brien, R. R. Benoit, and S. F. Gould Corticotropin-Releasing Hormone Increases the Expression of the Prostaglandin E2 Receptor Subtype EP1 in Amnion WISH Cells Biol Reprod, January 1, 2000; 62(1): 23 - 26. [Abstract] [Full Text]

				L. J. Heffner, M. Kumari, and L. A. Benoit Secretion of the Vasoactive Peptides, Endothelin, and Parathyroid Hormone-Related Peptide, by Decidual Explants From Pregnancies Complicated by Intrauterine Growth Restriction Reproductive Sciences, September 1, 1999; 6(5): 273 - 277. [Abstract] [PDF]

				R. A. Nowak, F. Haimovici, J. D. Biggers, and G. T. Erbach Transforming Growth Factor-ß Stimulates Mouse Blastocyst Outgrowth through a Mechanism Involving Parathyroid Hormone-Related Protein Biol Reprod, January 1, 1999; 60(1): 85 - 93. [Abstract] [Full Text]